These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 14624206

  • 21. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF.
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [Abstract] [Full Text] [Related]

  • 22. Combined therapy with thioridazine decreases plasma levels of quetiapine inTaiwanese schizophrenic patients.
    Chang SC, Lu ML, Wang YC, Lin FW, Huang SH, Kuo PH, Ho HO, Wu TH.
    Ther Drug Monit; 2012 Jun; 34(3):345-8. PubMed ID: 22569350
    [Abstract] [Full Text] [Related]

  • 23. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions.
    Atmaca M, Kuloglu M, Tezcan E.
    Int J Impot Res; 2005 Jun; 17(2):201-3. PubMed ID: 15284834
    [Abstract] [Full Text] [Related]

  • 24. Does quetiapine have mood altering properties?
    Mishra A, Moore PB, Hobbs R.
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [Abstract] [Full Text] [Related]

  • 25. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M, Gama CS, Sundram S, Hustig H, Koopowitz L, D'Souza R, Malloy H, Rowland C, Monkhouse A, Monkhouse A, Bole F, Sathiyamoorthy S, Piskulic D, Dodd S.
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [Abstract] [Full Text] [Related]

  • 26. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
    Leweke FM, Gerth CW, Koethe D, Nolden BM, Klosterkötter J.
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
    [Abstract] [Full Text] [Related]

  • 27. Extended release quetiapine fumarate and pregnancy.
    Tényi T, Nagy Á, Herold R, Fekete S.
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):49-50. PubMed ID: 23542759
    [Abstract] [Full Text] [Related]

  • 28. Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report.
    Ozer S, Arsava M, Ertuğrul A, Demir B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):724-7. PubMed ID: 16414169
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
    Möller HJ, Johnson S, Mateva T, Brecher M, Svensson O, Miller F, Meulien D, Study 146 Investigators.
    Int Clin Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18301124
    [Abstract] [Full Text] [Related]

  • 30. An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
    Brunette MF, Akerman SC, Dawson R, O'Keefe CD, Green AI.
    Alcohol; 2016 Jun; 53():45-50. PubMed ID: 27256763
    [Abstract] [Full Text] [Related]

  • 31. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [Abstract] [Full Text] [Related]

  • 32. [Functional role of dopamine D3 receptor in schizophrenia].
    Semba J.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
    [Abstract] [Full Text] [Related]

  • 33. Serum prolactin and antipsychotic responses to pimozide in schizophrenia.
    Siris SG, van Kammen DP, De Fraites EG.
    Psychopharmacol Bull; 1978 Jan; 14(1):11-4. PubMed ID: 625528
    [No Abstract] [Full Text] [Related]

  • 34. Antipsychotic medications and fertility.
    Currier GW, Simpson GM.
    Psychiatr Serv; 1998 Feb; 49(2):175-6. PubMed ID: 9575000
    [No Abstract] [Full Text] [Related]

  • 35. Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion.
    Laakmann G, Schüle C, Baghai T, Waldvogel E, Bidlingmaier M, Strasburger C.
    J Clin Psychopharmacol; 2000 Feb; 20(1):101-3. PubMed ID: 10653218
    [No Abstract] [Full Text] [Related]

  • 36. Prolactin bioassay in medicated schizophrenics.
    Peabody CA, Clitherve SW, Warner DD, Boutros NN, Worsley IG, Friesen HG.
    Psychiatry Res; 1991 May; 37(2):207-9. PubMed ID: 1678893
    [No Abstract] [Full Text] [Related]

  • 37. [Chemotherapy in schizophrenic patients].
    Féline A.
    Rev Prat; 1972 Dec 11; 22(32):4485-99. PubMed ID: 4677004
    [No Abstract] [Full Text] [Related]

  • 38. Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions.
    Brunstein MG, Belmonte-de-Abreu P, Souza DO, Lara DR.
    J Clin Pharm Ther; 2001 Apr 11; 26(2):155-6. PubMed ID: 11350540
    [No Abstract] [Full Text] [Related]

  • 39. [The significance of prolactin levels in schizophrenia].
    Libiger J.
    Cesk Psychiatr; 1986 Oct 11; 82(5):337-41. PubMed ID: 3791466
    [No Abstract] [Full Text] [Related]

  • 40. Serum prolactin levels in unmedicated schizophrenic patients.
    Meltzer HY, Sachar EJ, Frantz AG.
    Arch Gen Psychiatry; 1974 Oct 11; 31(4):564-9. PubMed ID: 4422004
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.